Advantages of the avian model for human ovarian cancer (Review)

Author：      

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.6, 2015-01, pp. : 1191-1198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Study of Ovarian Cancer Chemoprevention Using Medroxyprogesterone Acetate in an Avian Model of Spontaneous Ovarian Carcinogenesis

By Barnes M.N.   Berry W.D.   Straughn J.M.J.   Kirby T.O.   Leath C.A.   Huh W.K.   Grizzle W.E.   Partridge E.E.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 57-63

Academic Press

Access to resources Recommend Favorite

Immunohistochemical Expression of Molecular Markers in an Avian Model: A Potential Model for Preclinical Evaluation of Agents for Ovarian Cancer Chemoprevention

By Rodrguez-Burford C.   Barnes M.N.   Berry W.   Partridge E.E.   Grizzle W.E.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 373-379

Elsevier

Access to resources Recommend Favorite

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model

By Vassileva Vessela   Grant Justin   Souza Raquel   Allen Christine   Piquette-Miller Micheline  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 907-914

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for advanced ovarian cancer: a review of the literature

By Dorff Tanya   Garcia Agustin  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 73-78

Informa Healthcare

Access to resources Recommend Favorite

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)

By          

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 642-647

Spandidos Publications

Access to resources Recommend Favorite